# Veradigm to Release Business Update May 26th and Host Investor Call May 27th
Canonical URL: https://biopharmsignal.com/news/MDRX/veradigm-to-release-business-update-may-26th-and-host-investor-call-may-27th
Ticker: MDRX
Company: Veradigm
Source: Veradigm
Published: 2026-06-25 13:46 EST
Original Source URL: https://investor.veradigm.com
## Summary

CHICAGO --(BUSINESS WIRE)--May 26, 2026-- Veradigm ® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on Tuesday, May 26, 2026.

## Article Body
CHICAGO --(BUSINESS WIRE)--May 26, 2026-- Veradigm ® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on Tuesday, May 26, 2026.
## Recent Company News
- 2026-06-25 13:46 EST — [Veradigm Files 2023 and 2024 Form 10-K](https://biopharmsignal.com/news/MDRX/veradigm-files-2023-and-2024-form-10-k) — Source: Veradigm
- 2026-06-25 13:46 EST — [Veradigm to Release Business Update May 26th and Host Investor Call May 27th](https://biopharmsignal.com/news/MDRX/veradigm-to-release-business-update-may-26th-and-host-investor-call-may-27th) — Source: Veradigm
- 2026-06-25 13:46 EST — [Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices](https://biopharmsignal.com/news/MDRX/veradigm-launches-health-network-architecture-to-level-the-playing-field-for-independent-practices) — Source: Veradigm
- 2026-06-25 13:46 EST — [Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity](https://biopharmsignal.com/news/MDRX/veradigm-and-meperia-launch-industry-first-8-way-match-edi-platform-to-strengthen-healthcare-supply-chain-integrity) — Source: Veradigm
- 2026-06-25 13:46 EST — [Veradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent Practices](https://biopharmsignal.com/news/MDRX/veradigm-launches-new-ai-application-for-powerful-revenue-cycle-insights-for-independent-practices) — Source: Veradigm
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)